Effect of administration of diethylcarbamazine with and without fluconazole on experimental fungal infections in mice.

[1]  L. Kitchen,et al.  Effect of administration of diethylcarbamazine on experimental bacterial and fungal infections in mice. , 1992, International journal of antimicrobial agents.

[2]  T. Patterson,et al.  The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis. , 1991, The Journal of infectious diseases.

[3]  E. Anaissie,et al.  Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. , 1991, The American journal of medicine.

[4]  D. R. Weber,et al.  Hepatosplenic candidiasis: successful treatment with fluconazole. , 1991, The American journal of medicine.

[5]  D. Denning,et al.  Pulmonary aspergillosis in the acquired immunodeficiency syndrome. , 1991, The New England journal of medicine.

[6]  Bilello Ja,et al.  Effect of administration of diethylcarbamazine on murine leukemia virus (Cas-Br-M) infected mice. , 1990 .

[7]  D. Denning,et al.  Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. , 1990, Reviews of infectious diseases.

[8]  G. Cole,et al.  Evaluation of a murine model of hepatic candidiasis , 1990, Journal of clinical microbiology.

[9]  F. Dromer,et al.  Role of IgG and complement component C5 in the initial course of experimental cryptococcosis. , 1989, Clinical and experimental immunology.

[10]  Kitchen Lw,et al.  Effect of continuous oral diethylcarbamazine treatment on lymphocyte counts of feline leukemia virus-infected cats. , 1988 .

[11]  K. Miller,et al.  Diethylcarbamazine prophylaxis for human loiasis. Results of a double-blind study. , 1988, The New England journal of medicine.

[12]  S. Sandroni,et al.  Effect of diethylcarbamazine on testing serum samples for retroviral antibodies , 1988, Serodiagnosis and Immunotherapy in Infectious Disease.

[13]  Kitchen Lw,et al.  Effect of diethylcarbamazine on serum antibody to feline oncornavirus-associated cell membrane antigen in feline leukemia virus cats. , 1988 .

[14]  T. Shawker,et al.  Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. , 1988, Annals of internal medicine.

[15]  P. Troke,et al.  Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. , 1987, The Journal of antimicrobial chemotherapy.

[16]  P. Troke,et al.  Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice , 1985, Antimicrobial Agents and Chemotherapy.

[17]  K. Tsuchiya,et al.  SCE-129, Antipseudomonal Cephalosporin: In Vitro and In Vivo Antibacterial Activities , 1978, Antimicrobial Agents and Chemotherapy.

[18]  R. Jones,et al.  Serodiagnosis of clinical cryptococcosis. , 1968, The American review of respiratory disease.

[19]  J. Kobayashi,et al.  Studies on the distribution of tritium labelled antifilarial drug 3H-diethylcarbamazine by whole body auto-radiography. , 1967 .

[20]  M. Gordon,et al.  Serologic tests in diagnosis and prognosis of cryptococcosis. , 1966, JAMA.

[21]  D. Bangham.  The mode of action of diethylcarbamazine investigated with 14C-labelled drug. , 1955, British Journal of Pharmacology and Chemotherapy.

[22]  F. Hawking,et al.  The mode of action of hetrazan on filarial worms. , 1950, British journal of pharmacology and chemotherapy.